COMP <GO>
WTS vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Watts Water Technologies Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: WTS 9
— TMO 4
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: WTS
LAST: $350.89 (+2.34%) • MKT CAP: $11.71B
roic
19.50%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WTS VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WTS | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 49.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 19.50% | 9.30% | +10.20 | WTS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.6x | 30.4x | -6.80 | WTS | /valuation <GO> |
| Free Cash Flow Yield | 3.04% | 2.40% | +0.64 | WTS | /fcf-yield <GO> |
| Operating Margin | 18.40% | 17.40% | +1.00 | WTS | /operating-margins <GO> |
| Net Profit Margin | 14.00% | 15.10% | -1.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 8.30% | 3.90% | +4.40 | WTS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.46 | 4.50 | +2.96 | WTS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | WTS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.4 | 62.9 | -16.50 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | 0.94 | +0.22 | WTS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 36.3x | -4.30 | WTS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.71B | $262.22B | -$250.50B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WTS REV | TMO REV | WTS GROSS % | TMO GROSS % | WTS FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.44B | $44.56B | 49.5% | — | $356.3M | $6.29B |
| FY 2024 | $2.25B | $42.88B | 47.2% | — | $325.8M | $7.27B |
| FY 2023 | $2.06B | $42.86B | — | — | $218.3M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WTS // BETA 1.16
TMO // BETA 0.94